OpenAI launches biopharma-focused AI model to compete with Anthropic
OpenAI is the latest tech giant to move into biopharma, announcing a life sciences-focused AI offering on Thursday. The San Francisco-based company announced GPT-Rosalind, effectively a version of ChatGPT tailored to the specialized work of ...
Original Source
Read the full article at Endpoints →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.